In accordance with the requirements of Regulation 30 and other applicable Regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), 2015, Eris Lifesciences has informed that analyst meet will be held on 3rd December 2018.
The above information is a part of company’s filings submitted to BSE.